Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments
Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) rapidly infects humans and animals which make coronavirus disease 2019 (COVID-19) a grievous epidemic worldwide which broke out in 2020. According to data analysis of the other coronavirus family, for instance severe acute respiratory...
Main Authors: | Zhi-Mei Liu, Ming-Hui Yang, Kun Yu, Zheng-Xing Lian, Shou-Long Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.989664/full |
Similar Items
-
Expression of toll-like receptors (tlrs) in the equine peripheral blood mononuclear cells (pbmcs) during the early pregnancy and estrous cycle
by: Ercan Kurar, et al. -
Reduced IL-8 Secretion by NOD-like and Toll-like Receptors in Blood Cells from COVID-19 Patients
by: Laura E. Carreto-Binaghi, et al.
Published: (2023-04-01) -
Profiling of bovine toll like receptors (TLRs) in foot and mouth disease vaccinated cattle
by: RAJEEV RANJAN, et al.
Published: (2016-04-01) -
Role of TLRs in HIV-1 Infection and Potential of TLR Agonists in HIV-1 Vaccine Development and Treatment Strategies
by: Marija Rozman, et al.
Published: (2023-01-01) -
The role of toll-like receptors (TLRs) in pan-cancer
by: Runzhi Huang, et al.
Published: (2022-12-01)